Results 61 to 70 of about 9,215 (199)

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

, 2007
Relapsed or treatment refractory B-cell lymphomas are currently incurable with conventional chemotherapy and radiation treatments. High-dose chemoradiotherapy and stem cell transplantation can cure some patients with relapsed or refractory lymphoma, but ...
Pagel, John M., Wilbur, D. Scott, Green, Damian J., Lin, Yukang, Hedin, Nathan, Hamlin, Donald K., Gopal, Ajay K., Pantelias, Anastasia, Press, Oliver W.   +8 more
core   +1 more source

Therapeutic dendritic cell vaccines engineered with antigen‐biomineralized Bi2S3 nanoparticles for personalized tumor radioimmunotherapy

Aggregate, 2022
Therapeutic vaccines, an exciting development in cancer immunotherapy, share the goal of priming of personalized antigen‐specific T‐cell response by precise antigen presentation of dendritic cells (DCs), but major obstacles include insufficient antigen ...
Huan Yu, Haoxiang Guo, He Zu, Heng Ding, Subin Lin, Yangyun Wang, Leshuai W Zhang, Yong Wang   +7 more
doaj   +1 more source

Radioimmunotherapy and colorectal cancer

British Journal of Surgery, 2005
AbstractBackgroundDespite the success of radioimmunotherapy (RIT) using radiolabelled monoclonal antibodies (Mabs) directed against tumour-associated antigens in the treatment of non-Hodgkin's lymphoma, therapeutic success in solid tumours has been modest. In the past decade, a dozen Mabs have been investigated clinically for their potential usefulness
Koppe, M.J., Bleichrodt, R.P., Oyen, W.J.G., Boerman, O.C.   +3 more
openaire   +4 more sources

Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation

Journal of Nanobiotechnology
The immunosuppressive tumor microenvironment (ITME) and inherent radioresistance of tumor cells limit the effectiveness of radioimmunotherapy and exacerbate immune evasion.
Ziting Xu, Yang Gao, Li Zhang, Yingshan Gao, Yushu Liao, Yu Liang, Zhen Yuan, Yingjia Li, Bingxia Zhao, Ge Wen   +9 more
doaj   +1 more source

Antibody conjugates in neuroblastoma: a step forward in precision medicine

Frontiers in Oncology
Neuroblastoma (NB) is a pediatric cancer that often manifests in a high-risk form and is characterized by frequent relapses and resistance to conventional therapies.
Jihane Balla, Carlotta Siddi, Maria Scherma, Paola Fadda, Paola Fadda, Simona Dedoni   +5 more
doaj   +1 more source

Radiotherapy‐Induced Side Effects: Epidemiology, Pathogenesis, Prevention and Treatments

MedComm, Volume 7, Issue 10, October 2026.
Radiotherapy for malignancies frequently injures the organs’ systems through oxidative stress, fibrosis, inflammation, and vascular damage. This review systematically maps the epidemiology, pathogenesis, and emerging therapies to propose a mechanism‑network‑targeted framework for integrated, personalized care in radiation oncology.
Xiaowen Ma, Xiaoxuan Zhang, Pujun Zhao, Jiaxin Yang, Zhihao Li, Xiaoyang Han, Yixuan Wang, Zhenzhen Cui, Nian Liu, Min Li   +9 more
wiley   +1 more source

Supplementary Data from Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma

, 2010
Supplementary Data from Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell ...
Donald Courter (251915), Albert Koong (259727), Quynh-Thu Le (251934), Sanjiv Sam Gambhir (1297), Xilin Sun (443667), Qizhen Cao (2644312), Xiaoyuan Chen (322516), Gang Niu (133768)   +7 more
core   +1 more source

Advances in radioimmunotherapy targeting prostate specific membrane antigen in prostate cancer

肿瘤影像学, 2015
Prostate specific membrane antigen (PSMA) is a transmembrane glycoprotein, which is almost expressed in all prostate cancers. The expression of PSMA in metastatic hormone-refractory prostate cancer is significantly increased.
LIU Chong
doaj  

Liver Metastases from Colorectal Cancer: From Pathogenesis to Current Treatment

MedComm, Volume 7, Issue 10, October 2026.
The liver is not merely a passive recipient of disseminated tumor cells, but a unique metastatic organ shaped by anatomical, metabolic, and immunological characteristics that support tumor colonization. Increasing evidence indicates that colorectal cancer liver metastasis development is driven by dynamic interactions between tumor intrinsic programs ...
Jialiang Fan, Huiru Zhang, Deyang Kong, Yu Sun, Shuaibing Lu, Wenjing Yang, Renshen Xiang, Qi Zhang, Wei Pei, Haizeng Zhang, Lin Feng   +10 more
wiley   +1 more source

“Boom-Boom” radioimmunotherapy of lymphomas. Are two magic bullets better than one?

, 2016
This is a commentarz on the use of radioimmunotherapy with Zevalin in the management of ...
John Prior, CICONE, FRANCESCO, SCOPINARO, Francesco   +2 more
core   +1 more source